ClinicalTrials.Veeva

Menu

Remote Ischaemic Conditioning for Fatigue After Stroke

NHS Foundation Trust logo

NHS Foundation Trust

Status

Completed

Conditions

Stroke Hemorrhagic
Fatigue
Stroke, Ischemic

Treatments

Procedure: Remote Ischaemic Conditioning
Procedure: Sham Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT03794947
STH19508

Details and patient eligibility

About

This is a pilot randomised control trial to assess the safety, compliance, and acceptability of delivering a 6-week programme of remote ischaemic conditioning (RIC) to stroke patients suffering with fatigue, and study feasibility. A minimum of 34 patients who have suffered an ischeamic or haemorrhagic stroke and who suffer from fatigue, will be recruited and randomised to receive a 6-week programme of either RIC or a sham intervention.

Full description

Up to 75% of stroke patients suffer from fatigue, the effect of which can be physical, cognitive or emotional, and presents a large barrier to progressing rehabilitation.

Remote ischaemic conditioning (RIC) is a procedure whereby ischaemia is induced to a limb for short periods of time by inflating pressure cuffs around arms or legs to above systolic pressures (mmHg). This procedure is performed for periods that avoid physical injury to the limbs, but induce neurohormonal, systemic or vascular changes in the body. Such changes often result in improved collateralisation of blood supply to various areas of the body, as well as improved efficiencies of cellular metabolism. This may enhance the physical abilities of patients undergoing rehabilitation after stroke, particularly when aiming to improve endurance and fatigue.

Enrollment

19 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (aged > 18 years) who have had an ischaemic or haemorrhagic stroke at least 6 weeks prior.
  • Symptoms of debilitating fatigue for at least 4 weeks (fatigues severity score of 28 or more).

Exclusion criteria

  • History or presence of significant peripheral vascular disease in the upper limbs.
  • History or presence of complex neuropathic pains or peripheral neuropathy in the arms.
  • Presence of lymphoedema in the arms.
  • Presence of skin ulceration to the arms.
  • Hospitalisation for cardiovascular or cerebrovascular disease within the last 4 weeks.
  • Uncontrolled arrhythmia, hypertension, diabetes or angina.
  • Third degree heart block or progressive heart failure.
  • Acute aortic dissection, myocarditis, or pericarditis.
  • Acute deep vein thrombosis, pulmonary embolism or pulmonary infection.
  • Suspected or known dissecting aneurysm.
  • Uncontrolled visual or vestibular disturbance.
  • Known or suspected cause of fatigue e.g. obstructive sleep apnoea (Epworth > 15), depression (PHQ-9 > 14).
  • Modified Rankin Score > 4.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

19 participants in 2 patient groups

Remote Ischaemic Conditioning
Experimental group
Description:
4 cycles of 5 minutes of upper or lower (depending on tolerability) limb ischaemia followed by 5 minutes of reperfusion. This will be delivered using a manual shygnomanometer applied to the upper arm or leg and activated to go through 4 such cycles automatically. The blood pressure cuff in the active treatment arm will inflate to 200 mmHg (arm) and 220 mmHg (leg). RIC will be completed 3 times weekly for 4 weeks.
Treatment:
Procedure: Remote Ischaemic Conditioning
Sham Intervention
Sham Comparator group
Description:
4 cycles of 5 minutes of upper or lower (depending on tolerability) limb ischaemia followed by 5 minutes of reperfusion. This will be delivered using a manual shygnomanometer applied to the upper arm or leg and activated to go through 4 such cycles automatically. The arm and leg blood pressure cuffs in the sham intervention will inflate to 20mmHg. Sham will be completed 3 times weekly for 4 weeks.
Treatment:
Procedure: Sham Intervention

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Alessia Dunn

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems